FLT3 Tyrosine Kinase Inhibitors: Comparison
View Latest Version
Please note this is a comparison between Version 1 by Michael Loschi and Version 4 by Camila Xu.

FLT3 is a member of the class III receptor tyrosine kinase family that exerts a key role in the proliferation and differentiation of hematopoietic progenitor cells. FLT3 inhibitors have dramatically altered the prognosis of the FLT3 mutant AML.

  • FMS-like tyrosine kinase 3 (FLT3)
  • acute myeloid leukemia
Please wait, diff process is still running!
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback